Re: HIV e AIDS
Inviato da sitchinite il 11/12/2009 16:11:47
Ultime notizie:
http://www.tgcom.mediaset.it/mondo/articoli/articolo468249.shtml
I ricercatori della Ucla, l'Università californiana di Los Angeles, hanno scoperto che le cellule del sangue possono essere trattate in modo da poter attaccare e sconfiggere le cellule colpite dal virus dell'Hiv, responsabile dell'Aids. Lo studio, pubblicato dal giornale online Plos One, dimostrerebbe che è possibile "modificare le cellule del sangue umano in modo da renderle equivalenti a un vaccino genetico".
http://www.sciencedaily.com/releases/2009/12/091208132732.htm
The study, published Dec. 7 in the-peer reviewed online journal PLoS One, provides proof-of-principle -- that is, a demonstration of feasibility -- that human stem cells can be engineered into the equivalent of a genetic vaccine.
"We have demonstrated in this proof-of-principle study that this type of approach can be used to engineer the human immune system, particularly the T-cell response, to specifically target HIV-infected cells," said lead investigator Scott G. Kitchen, assistant professor of medicine in the division of hematology and oncology at the David Geffen School of Medicine at UCLA and a member of the UCLA AIDS Institute. "These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of viruses that cause chronic disease, or even different types of tumors."
http://www.tgcom.mediaset.it/mondo/articoli/articolo468249.shtml
I ricercatori della Ucla, l'Università californiana di Los Angeles, hanno scoperto che le cellule del sangue possono essere trattate in modo da poter attaccare e sconfiggere le cellule colpite dal virus dell'Hiv, responsabile dell'Aids. Lo studio, pubblicato dal giornale online Plos One, dimostrerebbe che è possibile "modificare le cellule del sangue umano in modo da renderle equivalenti a un vaccino genetico".
http://www.sciencedaily.com/releases/2009/12/091208132732.htm
The study, published Dec. 7 in the-peer reviewed online journal PLoS One, provides proof-of-principle -- that is, a demonstration of feasibility -- that human stem cells can be engineered into the equivalent of a genetic vaccine.
"We have demonstrated in this proof-of-principle study that this type of approach can be used to engineer the human immune system, particularly the T-cell response, to specifically target HIV-infected cells," said lead investigator Scott G. Kitchen, assistant professor of medicine in the division of hematology and oncology at the David Geffen School of Medicine at UCLA and a member of the UCLA AIDS Institute. "These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of viruses that cause chronic disease, or even different types of tumors."
Messaggio orinale: https://old.luogocomune.net/site/newbb/viewtopic.php?forum=49&topic_id=186&post_id=154087